- Janus Kinase Inhibitors in the Treatment of Alopecia Areata2023 | Third Faculty of Medicine
- Protein Kinase Inhibitors2006 | First Faculty of Medicine
- Incidence of second malignancies during treatment of chronic myeloid leukemia with tyrosine kinase inhibitors in the Czech Republic and Slovakia2011 | Faculty of Medicine in Hradec Králové
- Tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma2020 | First Faculty of Medicine
- Termination of the treatment in chronic myeloid leukemia - possi bility of stopping the tyrosine kinase inhibitors2017 | First Faculty of Medicine
- Indication of EGFR Kinase Inhibitors Should Be Refined2011 | Third Faculty of Medicine
- Discontinuation of biological therapy with tyrosine kinase inhibitors in chronic myeloid leukemia patients2014 | Faculty of Medicine in Pilsen
- Efficacy of Janus kinase inhibitors on skin syndrome in patients with psoritic arthritis2022 | First Faculty of Medicine
- Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia patients - worldwide battlefield2015 | Faculty of Medicine in Pilsen
- Current approach for chronic myeloid leukemia treatment with tyrosin kinase inhibitors2016 | First Faculty of Medicine
- Bruton's tyrosine kinase inhibitors and their current status in the treatment of chronic lymphocytic leukemia2023 | First Faculty of Medicine
- Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy2024 | Publication without faculty affiliation
- MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma2018 | First Faculty of Medicine
- Resorcylic acid lactones as protein kinase inhibitors and naturally occurring toxins2013 | Publication without faculty affiliation
- LC-MS/MS method for determination of cyclin-dependent kinase inhibitors, BP-14 and BP-20, and its application in pharmacokinetic study in rat2018 | Faculty of Pharmacy in Hradec Králové
- Nanomedicine of tyrosine kinase inhibitors2021 | Faculty of Science, Second Faculty of Medicine
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Central Library of Charles University
- Identification of Enzymes Oxidizing the Tyrosine Kinase Inhibitor Cabozantinib: Cabozantinib Is Predominantly Oxidized by CYP3A4 and Its Oxidation Is Stimulated by cyt b(5) Activity2020 | Faculty of Science
- Possible discontinuation of treatment by tyrosine kinase inhibitors in patients with chronic myeloid leukemia and concept of treatment-free remission2017 | Publication without faculty affiliation
- Clinical experience with Janus kinase inhibitors2019 | First Faculty of Medicine
- Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro2018 | Faculty of Science
- Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy2020 | Faculty of Medicine in Hradec Králové
- Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon-alpha 2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial2011 | Faculty of Medicine in Hradec Králové
- Direct salting-out assisted liquid-liquid extraction (SALLE) from human blood: Application for the analysis of tyrosine kinase inhibitors2020 | Faculty of Science
- Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial2018 | Publication without faculty affiliation
- Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro2015 | Faculty of Pharmacy in Hradec Králové
- Study of two tyrosine kinase inhibitors on growth and signal transduction in polycythemia vera2007 | First Faculty of Medicine
- Study of two tyrosine kinase inhibitors on growth and signal transduction in polycythemia vera2007 | Faculty of Physical Education and Sport
- Radiosensitization of Human Leukemic HL-60 Cells by ATR Kinase Inhibitor (VE-821): Phosphoproteomic Analysis2014 | Faculty of Medicine in Hradec Králové
- Where does treatment of chronic myeloid leukemia target tyrosine kinase inhibitors?2018 | First Faculty of Medicine